Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03144180
Other study ID # E17020
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 19, 2017
Est. completion date November 28, 2017

Study information

Verified date December 2019
Source Texas Tech University Health Sciences Center, El Paso
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Currently there is no standardized method of collecting and transferring umbilical cord blood to laboratory vacuum tubes. Current methods are messy and may require needles to draw the blood presenting risk of blood exposure and percutaneous injury to obstetrical personnel. A safer, more efficient method of collecting cord blood is needed. The investigators propose to use the Q-Cup technology for collecting cord blood. The Q-Cup device is a two-piece injection molded blood collection and transfer device that enables safe and easy collection of blood from the newborn's umbilical cord and readily transfers the blood into a laboratory vacuum tube. The device consists of a collection cup with a wide opening to easily collect blood from the umbilical cord and a guide tube with a recessed needle which is attached to the collection cup. The operator is enabled to fill the required vacuum containing tubes in a clean, quick, efficient and safe manner by simply inserting the vacuum tube into the guide tube of the Q-Cup. As a result, there is less risk of blood exposure and percutaneous injury and blood is collected more efficiently. This device allows the practitioner to collect and transfer umbilical cord blood: without the need for removing the stopper from the vacuum tube (reducing mess and contamination) and without the need for a syringe and exposed needle (reducing injury and infection).


Description:

Approximately 4 million babies were born in the United States in 2015. Umbilical cord blood (UBC) collection is a routine hospital procedure done to evaluate a newborn's health after the birth of the fetus. UBC is tested to measure bilirubin levels, blood gases, blood sugar levels, blood types, complete blood counts, and platelet counts. UBC is collected by either draining the blood into the collection vial, milking the umbilical cord of blood, or extracting the blood by injecting a needle with a syringe. The Center for Disease Control (CDC) estimates 5.6 million workers in the health care industry are at risk of occupational exposure to bloodborne pathogens. Occupational exposure during umbilical cord blood collection may occur due to the great deal of blood and amniotic fluid present at the time of delivery. This fluid causes the physician to have a slippery grasp on the umbilical cord and vials for collection. These methods pose a risk of exposing Labor and Delivery staff to blood borne diseases. The drainage and milking method can lead to an increased amount of spilled blood while the extraction method may lead to accidental needle sticks. Exposure to bloodborne pathogens may be amplified when the umbilical cord is engorged with blood and as the needle is inserted in the cord, splatter may occur. The Needlestick Safety and Prevention Act was signed into law on November 6, 2000 in which employees were required to implement safer medical devices. Many patents have been obtained for umbilical cord blood collection devices however, there has not been a standardized method of collecting and transferring umbilical cord blood to the laboratory vacuum tubes. The goal of this project is to prove the feasibility of using the Q-Cup, a patent pending disposable, two-piece blood collection and transfer device for safely and efficiently collecting umbilical cord blood and transferring it into laboratory vacuum tubes.

The overall objective of this project is to prove the feasibility of using a two-piece umbilical blood collection and transfer device for safely and effectively collecting umbilical cord blood and transferring the blood into a laboratory vacuum tube. Also, the investigators will assess provider satisfaction, safety, ease of use, length of procedure comparing passive flow into blood tubes and the Q-cup technology. The Q-Cup technology can take part in the effort to reduce occupation exposures including percutaneous exposures during labor and delivery in general and by studying specifically the heretofore neglected category of umbilical cord blood collection and transfer. Efforts in this area will help focus attention on this previously ignored domain and help establish a standard of care and safety during this frequent procedure.

The investigators hypothesize the Q-Cup will be a more effective transfer method than current practices utilized for umbilical cord blood collection.


Recruitment information / eligibility

Status Completed
Enrollment 32
Est. completion date November 28, 2017
Est. primary completion date September 14, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- Obstetric patients must be age 18 or older

- Obstetric patients must be receiving prenatal care at Texas Tech University Health Sciences Center El Paso Department of Ob-Gyn

- Obstetric patients must be in their third trimester

- Obstetric patients must be delivering at University Medical Center

Exclusion Criteria:

- children will not be included

- patients in active labor

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Q-cup
This technology is a different way of collecting umbilical cord blood.

Locations

Country Name City State
United States Texas Tech University Health Sciences Center El Paso El Paso Texas

Sponsors (1)

Lead Sponsor Collaborator
Texas Tech University Health Sciences Center, El Paso

Country where clinical trial is conducted

United States, 

References & Publications (2)

Eder JM, Cutter GR. A new device for collecting cord blood. Obstet Gynecol. 1995 Nov;86(5):850-2. — View Citation

Perry J, Jagger J. Collecting umbilical cord blood. Nursing. 2004 Oct;34(10):20. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Mean Blood Collection Time Anticipating the average lengths of cord blood collection with the standard method is 15 seconds and 30 seconds with the Q-cup, we needed 30 subjects total. 15 in the Q-cup arm of the study and 15 in the comparison group (for a two-sided two-sample t-test with 80% power, an alpha of 0.05, and a common standard deviation of 14 seconds). 30 participants were recruited into the study, however, the delivery providers were in charge of collecting this outcome. 12 weeks
Secondary Determining Umbilical Cord Collection Cleanliness With the Q-cup as Compared to the Standard Blood Collection Method Participants' delivery providers were asked to self-administer a survey in which they were to assess blood collection for cleanliness. Possible choices were excellent/ good or fair/poor. Some delivery providers did not fill out the surveys and therefore, data was missing. At Delivery which could be between 1 to 12 weeks after Baseline.
Secondary Fill Capacity of Umbilical Cord Blood Using the Qcup Compared to Standard of Care Participant delivery providers were asked to self-administer a survey in which they were to assess the fill capacity of the lab tubes using the Qcup or the standard method. Possible choices were filled to capacity and not filled to capacity. Some delivery providers did not fill out the surveys and therefore, data was missing. 12 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04786314 - The Effect of Hot and Cold Water Application on Pregnant Women With Restless Leg Syndrome N/A
Completed NCT02527005 - A Comparative Study of Azithromycin and S-P as Prophylaxis in Pregnant HIV+ Patients Phase 1
Completed NCT02189356 - Gulhane Military Medical Academy Ethical Committee Exercise Program for Pregnant Women With Low Back and Pelvic Pain N/A
Recruiting NCT04417283 - Project HOPE 1000: Health Outcomes Pregnancy Exposures
Completed NCT03105492 - Pregnant Women s Views About the Ethics of Prenatal Whole Genome Sequencing
Not yet recruiting NCT06239753 - The Impact of Dynamic Neuromuscular Stabilization on Pregnancy N/A
Completed NCT03680235 - Informational Intervention in Increasing Lactation Practices by African American Women N/A
Completed NCT05725746 - Feasibility of Remote Data Collection With a Point of Care Device to Measure HbA1c
Active, not recruiting NCT03664648 - DV2-HBV-27: Observational Pregnancy Registry
Completed NCT05715476 - The Effect of Different Altitude Levels on Spinal Anesthesia in Cesarean Section Surgery N/A
Completed NCT05578729 - The Effect of Different Masks Used by Pregnant Women on Vital Signs and Non Stress Test During The COVID-19 N/A
Withdrawn NCT01307839 - Lidocaine Patch for Relief of Pain During Epidural Placement in Laboring Patients N/A
Completed NCT03383653 - Safety Profile Following Td Vaccination in Indonesian Pregnant Woman N/A
Recruiting NCT03688087 - Study of Programm Interest 'Bouge' to Improve the Daily Physical Activity at the Pregnant Women. N/A
Active, not recruiting NCT03079258 - Physical Activity and Vascular Health During Pregnancy N/A

External Links